主要股东
注:以下部分股东代表特定权益共同体,直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | Amir Elstein | 否 | 210.40万 | -- |
|
|
-- |
| 2 | Richard Francis | 否 | 117.06万 | -- |
|
|
-- |
| 3 | Roberto A. Mignone | 否 | 47.29万 | -- |
|
|
-- |
| 4 | Sol J. Barer | 否 | 42.63万 | -- |
|
|
-- |
| 5 | Eli Kalif | 否 | 32.54万 | -- |
|
|
-- |
| 6 | Gerald M. Lieberman | 否 | 11.57万 | -- |
|
|
-- |
| 7 | Rosemary A. Crane | 否 | 11.32万 | -- |
|
|
-- |
| 8 | Eric A. Hughes | 否 | 10.77万 | -- | 新增 | 新增 | -- |
| 9 | Perry D. Nisen | 否 | 10.53万 | -- |
|
|
-- |
| 10 | Ronit Satchi Fainaro | 否 | 9.79万 | -- |
|
|
-- |
| 11 | Evan Lippman | 否 | 8.58万 | -- | 新增 | 新增 | -- |
| 12 | Christine Fox | 否 | 8.49万 | -- |
|
|
-- |
| 13 | Janet S. Vergis | 否 | 7.37万 | -- |
|
|
-- |
| 14 | Tal Zaks | 否 | 5.88万 | -- |
|
|
-- |
| 15 | Varda Shalev | 否 | 2.25万 | -- |
|
|
-- |
| 16 | Chen Lichtenstein | 否 | 0.48万 | -- | 新增 | 新增 | -- |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2026-06-03 | Shields Matthew |
|
2.62 | -- | 是 | EVP, Global Operations |
| 2026-06-03 | Shields Matthew |
|
1.00 | 32.87 | 是 | EVP, Global Operations |
| 2026-05-14 | Kalif Eliyahu Sharon |
|
17.22 | 35.61 | 是 | EVP, Chief Financial Officer |
| 2026-05-14 | Lippman Evan |
|
8.01 | -- | 是 | EVP, Business Development |
| 2026-05-14 | Lippman Evan |
|
4.42 | 35.58 | 是 | EVP, Business Development |
| 2026-05-14 | Lippman Evan |
|
1.18 | -- | 是 | EVP, Business Development |
| 2026-05-14 | Lippman Evan |
|
0.61 | 35.58 | 是 | EVP, Business Development |
| 2026-05-06 | Weiss Amir |
|
2.00 | 36.00 | 是 | Chief Accounting Officer |
| 2026-05-05 | Daniell Richard |
|
5.58 | 35.40 | 是 | EVP, Europe Commercial |
| 2026-05-01 | Sabag Mark |
|
8.08 | 34.99 | 是 | Executive Vice President, International Markets Commercial |
| 2026-04-30 | Fox Christine |
|
6.36 | 35.31 | 是 | EVP, U.S. Commercial |
| 2026-03-17 | Sabag Mark |
|
22.49 | 30.14 | 是 | Executive Vice President, International Markets Commercial |
| 2026-03-05 | Shields Matthew |
|
2.73 | -- | 是 | EVP, Global Operations |
| 2026-03-05 | Shields Matthew |
|
1.00 | 31.67 | 是 | EVP, Global Operations |
| 2026-03-05 | Savage Brian |
|
1.20 | -- | 是 | Interim Chief Legal Officer |
| 2026-03-05 | Savage Brian |
|
1.09 | 31.67 | 是 | Interim Chief Legal Officer |
| 2026-03-05 | Jover Placid |
|
2.09 | -- | 是 | Executive Vice President, Chief Human Resources Officer |
| 2026-03-05 | Jover Placid |
|
0.68 | 31.67 | 是 | Executive Vice President, Chief Human Resources Officer |
| 2026-03-05 | Daniell Richard |
|
10.31 | -- | 是 | EVP, Europe Commercial |
| 2026-03-05 | Daniell Richard |
|
8.58 | 31.67 | 是 | EVP, Europe Commercial |
| 2026-03-05 | Hughes Eric A |
|
11.72 | -- | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2026-03-05 | Hughes Eric A |
|
10.77 | 31.67 | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2026-03-05 | Fox Christine |
|
9.28 | -- | 是 | EVP, U.S. Commercial |
| 2026-03-05 | Fox Christine |
|
8.49 | 31.67 | 是 | EVP, U.S. Commercial |
| 2026-03-05 | Francis Richard D |
|
119.07 | -- | 是 | President and CEO |
| 2026-03-05 | Francis Richard D |
|
117.06 | 31.67 | 是 | President and CEO |
| 2026-03-05 | Weiss Amir |
|
3.07 | -- | 是 | Chief Accounting Officer |
| 2026-03-05 | Kalif Eliyahu Sharon |
|
32.54 | -- | 是 | EVP, Chief Financial Officer |
| 2026-03-05 | Sabag Mark |
|
28.70 | -- | 是 | Executive Vice President, International Markets Commercial |
| 2026-03-04 | Weiss Amir |
|
2.15 | -- | 是 | Chief Accounting Officer |
| 2026-03-04 | Weiss Amir |
|
2.72 | -- | 是 | Chief Accounting Officer |
| 2026-03-04 | Savage Brian |
|
0.77 | -- | 是 | Interim Chief Legal Officer |
| 2026-03-04 | Savage Brian |
|
0.62 | 32.46 | 是 | Interim Chief Legal Officer |
| 2026-03-04 | Savage Brian |
|
0.96 | -- | 是 | Interim Chief Legal Officer |
| 2026-03-04 | Savage Brian |
|
0.85 | 32.46 | 是 | Interim Chief Legal Officer |
| 2026-03-04 | Fox Christine |
|
8.41 | -- | 是 | EVP, U.S. Commercial |
| 2026-03-04 | Fox Christine |
|
7.50 | 32.46 | 是 | EVP, U.S. Commercial |
| 2026-03-04 | Kalif Eliyahu Sharon |
|
28.23 | -- | 是 | EVP, Chief Financial Officer |
| 2026-03-04 | Kalif Eliyahu Sharon |
|
30.55 | -- | 是 | EVP, Chief Financial Officer |
| 2026-03-04 | Hughes Eric A |
|
10.89 | -- | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2026-03-04 | Hughes Eric A |
|
9.76 | 32.46 | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2026-03-04 | Sabag Mark |
|
25.27 | -- | 是 | Executive Vice President, International Markets Commercial |
| 2026-03-04 | Sabag Mark |
|
27.13 | -- | 是 | Executive Vice President, International Markets Commercial |
| 2026-03-04 | Daniell Richard |
|
15.66 | -- | 是 | EVP, Europe Commercial |
| 2026-03-04 | Daniell Richard |
|
12.31 | 32.46 | 是 | EVP, Europe Commercial |
| 2026-03-04 | Daniell Richard |
|
14.36 | -- | 是 | EVP, Europe Commercial |
| 2026-03-04 | Daniell Richard |
|
12.31 | 32.46 | 是 | EVP, Europe Commercial |
| 2026-03-04 | Daniell Richard |
|
8.58 | 32.95 | 是 | EVP, Europe Commercial |
| 2026-03-04 | Francis Richard D |
|
117.16 | -- | 是 | President and CEO |
| 2026-03-04 | Francis Richard D |
|
114.82 | 32.46 | 是 | President and CEO |
| 2026-03-03 | Hughes Eric A |
|
2.49 | -- | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2026-03-03 | Hughes Eric A |
|
1.28 | 32.36 | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2026-03-03 | Hughes Eric A |
|
15.43 | -- | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2026-03-03 | Hughes Eric A |
|
8.56 | 32.36 | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2026-03-03 | Kalif Eliyahu Sharon |
|
10.73 | -- | 是 | EVP, Chief Financial Officer |
| 2026-03-03 | Kalif Eliyahu Sharon |
|
24.88 | -- | 是 | EVP, Chief Financial Officer |
| 2026-03-03 | Francis Richard D |
|
67.30 | -- | 是 | President and CEO |
| 2026-03-03 | Francis Richard D |
|
64.21 | 32.36 | 是 | President and CEO |
| 2026-03-03 | Francis Richard D |
|
153.34 | -- | 是 | President and CEO |
| 2026-03-03 | Francis Richard D |
|
112.14 | 32.36 | 是 | President and CEO |
| 2026-03-03 | Savage Brian |
|
0.42 | -- | 是 | Interim Chief Legal Officer |
| 2026-03-03 | Savage Brian |
|
0.29 | 32.36 | 是 | Interim Chief Legal Officer |
| 2026-03-03 | Sabag Mark |
|
7.77 | -- | 是 | Executive Vice President, International Markets Commercial |
| 2026-03-03 | Sabag Mark |
|
21.92 | -- | 是 | Executive Vice President, International Markets Commercial |
| 2026-03-03 | Daniell Richard |
|
11.06 | -- | 是 | EVP, Europe Commercial |
| 2026-03-03 | Daniell Richard |
|
4.84 | 32.36 | 是 | EVP, Europe Commercial |
| 2026-03-03 | Daniell Richard |
|
18.99 | -- | 是 | EVP, Europe Commercial |
| 2026-03-03 | Daniell Richard |
|
12.31 | 32.36 | 是 | EVP, Europe Commercial |
| 2026-03-03 | Weiss Amir |
|
1.08 | -- | 是 | Chief Accounting Officer |
| 2026-02-26 | Kalif Eliyahu Sharon |
|
5.75 | 33.64 | 是 | EVP, Chief Financial Officer |
| 2026-02-15 | Francis Richard D |
|
43.34 | -- | 是 | President and CEO |
| 2026-02-15 | Francis Richard D |
|
27.18 | 34.22 | 是 | President and CEO |
| 2026-02-15 | Francis Richard D |
|
89.19 | -- | 是 | President and CEO |
| 2026-02-15 | Francis Richard D |
|
60.58 | 34.22 | 是 | President and CEO |
| 2025-12-16 | Weiss Amir |
|
0.57 | 30.20 | 是 | Chief Accounting Officer |
| 2025-12-09 | Sabag Mark |
|
26.97 | 18.61 | 是 | Executive Vice President, International Markets Commercial |
| 2025-12-09 | Sabag Mark |
|
15.10 | 28.75 | 是 | Executive Vice President, International Markets Commercial |
| 2025-12-09 | Sabag Mark |
|
5.28 | 28.70 | 是 | Executive Vice President, International Markets Commercial |
| 2025-12-09 | Daniell Richard |
|
14.88 | 18.61 | 是 | Exec. VP, European Commercial |
| 2025-12-09 | Daniell Richard |
|
16.39 | 16.99 | 是 | Exec. VP, European Commercial |
| 2025-12-09 | Daniell Richard |
|
4.84 | 28.68 | 是 | Exec. VP, European Commercial |
| 2025-12-02 | Lichtenstein Chen |
|
0.48 | -- | 是 | -- |
| 2025-11-20 | Fox Christine |
|
9.19 | -- | 是 | EVP, Head of U.S. Commercial |
| 2025-11-20 | Fox Christine |
|
6.36 | 24.78 | 是 | EVP, Head of U.S. Commercial |
| 2025-11-14 | Fox Christine |
|
2.84 | 25.11 | 是 | EVP, Head of U.S. Commercial |
| 2025-11-06 | Weiss Amir |
|
1.80 | 24.44 | 是 | Chief Accounting Officer |
| 2025-09-05 | McAvoy David R. |
|
1.30 | 18.86 | 是 | EVP, Chief Legal Officer |
| 2025-08-01 | Hughes Eric A |
|
5.27 | -- | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2025-08-01 | Hughes Eric A |
|
-- | 15.16 | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2025-08-01 | Jover Placid |
|
1.28 | -- | 是 | Executive Vice President, Chief Human Resources Officer. |
| 2025-08-01 | Jover Placid |
|
0.68 | 15.16 | 是 | Executive Vice President, Chief Human Resources Officer. |
| 2025-06-12 | Kalif Eliyahu Sharon |
|
40.33 | 17.08 | 是 | EVP, Chief Financial Officer |
| 2025-06-05 | MIGNONE ROBERTO |
|
10.53 | -- | 是 | -- |
| 2025-06-05 | BARER SOL J |
|
42.63 | -- | 是 | -- |
| 2025-06-05 | Crane Rosemary A |
|
11.32 | -- | 是 | -- |
| 2025-06-05 | Elstein Amir |
|
210.40 | -- | 是 | -- |
| 2025-06-05 | LIEBERMAN GERALD M |
|
11.57 | -- | 是 | -- |
| 2025-06-05 | Nisen Perry |
|
10.53 | -- | 是 | -- |
| 2025-06-05 | Satchi-Fainaro Ronit |
|
9.79 | -- | 是 | -- |
| 2025-06-05 | Shalev Varda |
|
2.25 | -- | 是 | -- |
| 2025-06-05 | Zaks Tal Zvi |
|
5.88 | -- | 是 | -- |
| 2025-06-05 | Vergis Janet S. |
|
7.37 | -- | 是 | -- |
| 2025-06-03 | Shields Matthew |
|
1.62 | -- | 是 | EVP, Global Operations |
| 2025-06-03 | Shields Matthew |
|
1.00 | 17.02 | 是 | EVP, Global Operations |
| 2025-05-08 | Sabag Mark |
|
15.10 | 18.04 | 是 | Executive Vice President, International Markets Commercial |
| 2025-03-05 | Sabag Mark |
|
48.89 | -- | 是 | Executive Vice President, International Markets Commercial |
| 2025-03-05 | Daniell Richard |
|
11.93 | -- | 是 | Exec. VP, European Commercial |
| 2025-03-05 | Daniell Richard |
|
9.68 | 15.91 | 是 | Exec. VP, European Commercial |
| 2025-03-05 | Daniell Richard |
|
4.84 | 15.90 | 是 | Exec. VP, European Commercial |
| 2025-03-05 | Kalif Eliyahu Sharon |
|
45.91 | -- | 是 | EVP, Chief Financial Officer |
| 2025-03-05 | Weiss Amir |
|
3.03 | -- | 是 | Chief Accounting Officer |
| 2025-03-04 | Francis Richard D |
|
29.56 | -- | 是 | President and CEO |
| 2025-03-04 | Francis Richard D |
|
28.00 | 15.73 | 是 | President and CEO |
| 2025-03-04 | Francis Richard D |
|
27.18 | 15.91 | 是 | President and CEO |
| 2025-03-04 | Sabag Mark |
|
28.20 | -- | 是 | Executive Vice President, International Markets Commercial |
| 2025-03-04 | Sabag Mark |
|
46.51 | -- | 是 | Executive Vice President, International Markets Commercial |
| 2025-03-04 | Sabag Mark |
|
26.34 | -- | 是 | Executive Vice President, International Markets Commercial |
| 2025-03-04 | Kalif Eliyahu Sharon |
|
23.13 | -- | 是 | EVP, Chief Financial Officer |
| 2025-03-04 | Kalif Eliyahu Sharon |
|
25.45 | -- | 是 | EVP, Chief Financial Officer |
| 2025-03-04 | Kalif Eliyahu Sharon |
|
43.77 | -- | 是 | EVP, Chief Financial Officer |
| 2025-03-04 | Daniell Richard |
|
9.68 | 15.91 | 是 | Exec. VP, European Commercial |
| 2025-03-04 | Daniell Richard |
|
3.35 | -- | 是 | Exec. VP, European Commercial |
| 2025-03-04 | Daniell Richard |
|
1.16 | 15.73 | 是 | Exec. VP, European Commercial |
| 2025-03-04 | Daniell Richard |
|
-- | 15.91 | 是 | Exec. VP, European Commercial |
| 2025-03-04 | Daniell Richard |
|
2.05 | -- | 是 | Exec. VP, European Commercial |
| 2025-03-04 | Daniell Richard |
|
0.71 | 15.73 | 是 | Exec. VP, European Commercial |
| 2025-03-04 | Daniell Richard |
|
-- | 15.91 | 是 | Exec. VP, European Commercial |
| 2025-03-04 | Daniell Richard |
|
18.32 | -- | 是 | Exec. VP, European Commercial |
| 2025-03-04 | Daniell Richard |
|
12.68 | 15.73 | 是 | Exec. VP, European Commercial |
| 2025-03-04 | Hughes Eric A |
|
0.81 | 15.73 | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2025-03-04 | Hughes Eric A |
|
-- | 15.91 | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2025-03-04 | Hughes Eric A |
|
2.33 | -- | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2025-03-04 | Weiss Amir |
|
2.10 | -- | 是 | Chief Accounting Officer |
| 2025-03-04 | Weiss Amir |
|
2.67 | -- | 是 | Chief Accounting Officer |
| 2025-03-04 | McAvoy David R. |
|
1.19 | 15.91 | 是 | EVP, Chief Legal Officer |
| 2025-03-04 | McAvoy David R. |
|
1.67 | -- | 是 | EVP, Chief Legal Officer |
| 2025-03-04 | McAvoy David R. |
|
1.36 | 15.73 | 是 | EVP, Chief Legal Officer |
| 2025-03-04 | Fox Christine |
|
6.46 | -- | 是 | EVP, Head of U.S. Commercial |
| 2025-03-04 | Fox Christine |
|
6.05 | 15.73 | 是 | EVP, Head of U.S. Commercial |
| 2025-03-04 | Fox Christine |
|
5.84 | 15.91 | 是 | EVP, Head of U.S. Commercial |
| 2025-03-03 | Weiss Amir |
|
1.04 | -- | 是 | Chief Accounting Officer |
| 2025-03-03 | Sabag Mark |
|
22.99 | -- | 是 | Executive Vice President, International Markets Commercial |
| 2025-03-03 | Hughes Eric A |
|
2.49 | -- | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2025-03-03 | Hughes Eric A |
|
0.52 | 16.19 | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2025-03-03 | Hughes Eric A |
|
-- | 15.56 | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2025-03-03 | Francis Richard D |
|
25.18 | 16.19 | 是 | President and CEO |
| 2025-03-03 | Francis Richard D |
|
24.53 | 15.56 | 是 | President and CEO |
| 2025-03-03 | Francis Richard D |
|
27.67 | -- | 是 | President and CEO |
| 2025-03-03 | Daniell Richard |
|
6.23 | -- | 是 | Exec. VP, European Commercial |
| 2025-03-03 | Daniell Richard |
|
1.29 | 16.19 | 是 | Exec. VP, European Commercial |
| 2025-03-03 | Daniell Richard |
|
-- | 15.56 | 是 | Exec. VP, European Commercial |
| 2025-02-28 | Kalif Eliyahu Sharon |
|
14.79 | 16.21 | 是 | EVP, Chief Financial Officer |
| 2025-02-28 | Kalif Eliyahu Sharon |
|
19.77 | -- | 是 | EVP, Chief Financial Officer |
| 2025-02-15 | Francis Richard D |
|
28.50 | -- | 是 | President and CEO |
| 2025-02-15 | Francis Richard D |
|
20.94 | 16.95 | 是 | President and CEO |
| 2025-02-12 | Sabag Mark |
|
20.50 | 16.25 | 是 | Executive Vice President, International Markets Commercial |
| 2024-11-20 | Fox Christine |
|
6.35 | -- | 是 | EVP, Head of U.S. Commercial |
| 2024-11-20 | Fox Christine |
|
4.41 | 16.87 | 是 | EVP, Head of U.S. Commercial |
| 2024-09-02 | Shalev Varda |
|
1.29 | -- | 是 | -- |
| 2024-08-12 | Daniell Richard |
|
-- | 17.30 | 是 | Exec. VP, European Commercial |
| 2024-08-09 | Hughes Eric A |
|
-- | 17.38 | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2024-08-09 | Grant Angus |
|
1.29 | -- | 是 | EVP, Business Development |
| 2024-08-09 | Grant Angus |
|
0.88 | 17.28 | 是 | EVP, Business Development |
| 2024-08-01 | Hughes Eric A |
|
6.96 | -- | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2024-08-01 | Hughes Eric A |
|
4.51 | 17.25 | 是 | Executive Vice President, Global R&D and Chief Medical Officer |
| 2024-06-15 | LIEBERMAN GERALD M |
|
10.60 | -- | 是 | -- |
| 2024-06-15 | BARER SOL J |
|
40.91 | -- | 是 | -- |
| 2024-06-15 | MIGNONE ROBERTO |
|
159.57 | -- | 是 | -- |
| 2024-06-15 | Crane Rosemary A |
|
10.36 | -- | 是 | -- |
| 2024-06-15 | Vergis Janet S. |
|
6.41 | -- | 是 | -- |
| 2024-06-15 | Nisen Perry |
|
9.57 | -- | 是 | -- |
| 2024-06-15 | Zaks Tal Zvi |
|
4.91 | -- | 是 | -- |
| 2024-06-15 | Elstein Amir |
|
209.43 | -- | 是 | -- |
| 2024-06-15 | Satchi-Fainaro Ronit |
|
8.83 | -- | 是 | -- |